摘要
Abstract
Objective To provide a reference for the rational clinical use of enteral nutrition emulsion(TPF-T).Methods A total of 286 long-term medical orders for TPF-T from 163 patients(without clinical pharmacists' intervention)admitted to intensive care units,emergency departments(including resuscitation wards),gastrointestinal surgery,and oncology radiotherapy departments from January to March 2024 were selected as the control group,while 262 long-term medical orders for TPF-T from 180 patients(with pharmacists' intervention)admitted to those departments from April to June 2024 were selected as the intervention group.The rates of TPF-T orders with contraindications or inappropriate usage(severe renal insufficiency,severe hypoxemia,hypercapnia,or acidosis)were compared between the two groups.Results The mean ages of patients in the control group and intervention group were(68.87±14.27)years old and(69.16±12.67)years old,respectively,with 120 cases(73.62%)and 140 cases(77.78%)aged≥61 years.There were 34 orders(11.89%)in the control group and 14 orders(5.34%)involved TPF-T use in patients with severe renal insufficiency in the control group and the intervention group,respectively.The rate of contraindications or inappropriate usage was highest in the two groups,with 11.83%in the intervention group,which was significantly lower than 26.22%in the control group(χ2=18.153,P<0.001).Conclusion Continuous pharmaceutical intervention by clinical pharmacists in the long-term medication orders for TPF-T can standardize clinical rational use and improve medication safety.However,further improvements are still required.关键词
药学干预/肠内营养乳剂(TPF-T)/效果评价Key words
pharmaceutical intervention/enteral nutrition emulsion(TPF-T)/effect evaluation分类
药学
